FDA Details Product Tracing Exemptions Under the DSCSA

Drug GMP Report
A A
The FDA released a draft guidance explaining the circumstances when packages and cases are exempted from certain requirements of the 2013 Drug Supply Chain Security Act.

To View This Article:

Login

Subscribe To Drug GMP Report